While fans waited to catch Jasmine Sandlas and her powerhouse performance live on stage during her ‘The Dream Girl India’ tour, the singer had a lot more in store for fans. During her performance on ...

Hiding the relationship with Shekhar Chaudhary from eagle-eyed fans, Jasmine Sandlas kept it under the wraps for a long time. However, the ‘Shararat’ hitmaker often had her man by her side during ...

Jasmine Sandlas has added a personal milestone to her list of recent successes. During her live performance in Delhi on Saturday, the Dhurandhar singer announced that she is engaged to Shekhar ...

In case you've faced some hurdles solving the clue, Actor who played Jeevan Chaudhary in Station Eleven, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your ...

Jasmine Sandlas announced engagement to Shekhar Chaudhary. Announcement made during her Delhi performance. Shekhar Chaudhary is part of Sandlas's staff. Singer Jasmine Sandlas surprised her fans after ...

Fans attending Jasmine Sandlas's The Dream Girl India Tour were treated to more than just a memorable musical performance. They also witnessed a major surprise as the singer announced her engagement ...

THE TRIBUNE, India’s oldest, daily English-language newspaper, was first published on February 2, 1881, in Lahore (now in Pakistan), and save for 40 days in the immediate aftermath of Partition, has ...

Mahendra Kumar Chaudhary is the Executive Director and Chief Information Officer at the Oil and Natural Gas Corporation (ONGC). He has been credited with leading the drive to digitize the company’s ...

Managed by Talkiatry. Your call or email may go to a representative. Dr. Chhavi Chaudhary is a dual board-certified psychiatrist with subspecialty certification in Child and Adolescent Psychiatry. She ...

Punjabi singer Jasmine Sandlas surprised fans after announcing her engagement during the opening night of her Dream Girl India Tour in Delhi. Introducing her fiancé, Shekhar Chaudhary, on stage, the ...

Bansi Nagji discusses the shifting science behind rare and orphan drug development, including what it takes for therapies to succeed well beyond launch.